Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQ0R2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,613
Award facts
- Contract value 100% obligated
- $20,613.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,613.17 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2 mL on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant medication used to treat various autoimmune and inflammatory conditions, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders across multiple therapeutic domains through this flexible contract vehicle, supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQ0R2?
SPE2DB25FQ0R2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FQ0R2 worth?
The government has obligated $20,613 on SPE2DB25FQ0R2.
Is contract SPE2DB25FQ0R2 an order under another contract?
Yes. SPE2DB25FQ0R2 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ0R2 competed?
The extent of competition for SPE2DB25FQ0R2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award